Perspectives

Explore Strategic growth fields, hot topics and insights
Home Perspective

Life Sciences

Polymeric Biomaterials & Scaffolds: PLA, PLGA, PEEK and Beyond

body { margin:0; padding:0; } a { color:#f84e5d; } a:hover { color:#c93040; } .fb-solution { font-family:Arial,Helvetica,sans-ser...

Life Sciences

What Are Biomaterials?

body { margin:0; padding:0; } a { color:#f84e5d; } a:hover { color:#c93040; } .fb-solution { font-family:Arial,Helvetica,sans-se...

Life Sciences

How can your Biomaterial Innovation achieve commercial viability?

The Biomaterials Market Has Crossed $200 Billion. The Real Question Is: Which Innovations Will Actually Scale? Biomaterials are en...

Life Sciences

The GLP-1 Body Reset: Why the Beauty Industry’s Window to Act Is Rapidly Closing

100M+ Projected global GLP-1 users by 2030, from fewer than 15M today ...

Do Surgical Robotics Reduce Healthcare Costs or Add to Them?

Life Sciences

No procurement committee, hospital CFO, or R&D leadership team has fully cracked this question yet. When a surgical robot roll...

How are Wearables Redefining Remote Patient Monitoring in MedTech?

Life Sciences

Your R&D pipeline has the sensors. Your platform team has the connectivity. Your commercial team has the payer relationships. ...

How is AI transforming MedTech diagnostics?

Life Sciences

There is a number that every senior R&D leader in MedTech should keep close: 1,451. That is the count of AI and machine lea...

What is the Future of MedTech

Life Sciences

What is the Future of MedTech: The Inflection Point R&D Leaders Cannot Miss The question is no longer whether MedTech will tr...

What are the key trends in the medical device industry?

Life Sciences

What Are the Key Trends in the Medical Device Industry? The 3 Strategic Fault Lines Reshaping R&D   Every senior R&D...

2026 MedTech Trends Disrupted. Decentralized. Data-Driven.

Life Sciences

AI is infiltrating the OR. Supply chains are digitizing. Devices are becoming services.Is your strategy ready for the next era of ...

Gen AI Gold Rush, The Future of Medical Devices

Life Sciences

The $600 billion MedTech industry is entering its most transformative decade, powered by Generative AI.As algorithms evolve from p...

The $42B Question: Is MedTech Ready for GenAI?

Life Sciences

GenAI is shifting from concept to capability across MedTech. FutureBridge Analysts project a ~$42 billion healthcare market by 203...

Is the GLP-1 revolution the breakthrough your health strategy has been waiting for?

Life Sciences

GLP-1 therapies are no longer confined to diabetes and weight loss. They are expanding into metabolic health, healthy aging, neuro...

Breaking Barriers in Diabetes: Artificial Pancreas in Action

Life Sciences

Diabetes care is undergoing a defining transformation. For innovators in healthcare and medtech, the rise of artificial pancreas s...